In case anyone didn't understand my post (to which
Post# of 72440
Leo Ehrlich has done a great job as CEO. He has gotten us through successful clinical trials for 3 different drugs, and multiple applications for different diseases for the Brilacidin platform. All this, without taking on the kind of toxic debt that has doomed so many other small companies.
To blame him for the low share price, rather than blaming the attack by the Mako and other gangs, the Rosen bogus "shareholder" suit that was thrown out with prejudice, and the consistent bashing to scare away retail investors -- this is absurd. Without Leo's vision and persistence (especially in fighting the Rosen BS case), the company would not have accomplished all this.
I think that this stock should be trading around 5 at a minimum, given how far along the pipeline is. Just my opinion and not trading advice, of course